[1] Kluth LA, Black PC, Bochner BH, et al. Prognostic and prediction tools in bladder cancer: a comprehensive review of the literature[J]. Eur Urol, 2015, 68(2): 238-253. DOI: 10.1016/j.eururo.2015.01.032.
[2] Kim SW. The role of microRNAs in colorectal cancer[J]. Korean J Gastroenterol, 2017, 69(4): 206-211. DOI: 10.4166/kjg.2017.69.4.206.
[3] Ramchandran R, ChaluvallyRaghavan P. miRNAmediated RNA activation in mammalian cells[J]. Adv Exp Med Biol, 2017, 983: 81-89. DOI: 10.1007/978-981-10-4310-9_6.
[4] Huang B, Yang H, Cheng X, et al. tRF/miR1280 suppresses stem celllike cells and metastasis in colorectal cancer[J]. Cancer Res, 2017, 77(12): 3194-3206. DOI: 10.1158/0008-5472.CAN-16-3146.
[5] Vanacore D, Boccellino M, Rossetti S, et al. Micrornas in prostate cancer: an overview[J]. Oncotarget, 2017, 8(30): 50240-50251. DOI: 10.18632/oncotarget.16933.
[6] Sun V, Zhou WB, Nosrati M, et al. Antitumor activity of miR1280 in melanoma by regulation of Src[J]. Mol Ther, 2015, 23(1): 71-78. DOI: 10.1038/mt.2014.176.
[7] Meng D, Li Z, Ma X, et al. MicroRNA1280 modulates cell growth and invasion of thyroid carcinoma through targeting estrogen receptor α[J]. Cell Mol Biol (Noisylegrand), 2016, 62(3): 1-6.
[8] Kang MR, Li G, Pan T, et al. Development of therapeutic dsP21322 for cancer treatment[J]. Adv Exp Med Biol, 2017, 983: 217-229. DOI: 10.1007/978-981-10-4310-9_16.
[9] Li S, Wang C, Yu X, et al. miR36195p inhibits prostate cancer cell growth by activating CDKN1A expression[J]. Oncol Rep, 2017, 37(1): 241-248. DOI: 10.3892/or.2016.5250.
[10] Ge Q, Wang C, Chen Z, et al. The suppressive effects of miR11805p on the proliferation and tumorigenicity of bladder cancer cells[J]. Histol Histopathol, 2017, 32(1): 77-86. DOI: 10.14670/HH-11-772.
[11] Yan J, Hao C, DeLucia M, et al. CyclinA2cyclindependent kinase regulates SAMHD1 protein phosphohydrolase domain[J]. J Biol Chem, 2015, 290(21): 13279-13292. DOI: 10.1074/jbc.M115.646588.
[12] Zhao H, Zhang S, Xu D, et al. Expression of the p12 subunit of human DNA polymerase σ (Pol σ), CDK inhibitor p21(WAF1), Cdt1, cyclin A, PCNA and Ki-67 in relation to DNA replication in individual cells[J]. Cell Cycle, 2014, 13(22): 3529-3540. DOI: 10.4161/15384101.2014.958910.
[13] Tang K, Wang C, Chen Z, et al. Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer[J]. Int J Clin Exp Pathol, 2015, 8(5): 4999-5007. |